Document Detail


Cytochrome P-450 2D6 and 2C19 polymorphisms and length of hospitalization in psychiatry.
MedLine Citation:
PMID:  16812949     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We evaluated whether cytochrome P450 (CYP) poor metabolizer polymorphisms of CYP2D6 and CYP2C19 are relevant for the outcome (measured by length of hospitalization) during treatment with psychotropic medications in patients with depression or schizophrenia. 229 patients were genotyped by real-time PCR hybridization probe melting curve technique for CYP2C19*2, CYP2D6*3, *4, and *6, respectively. The gene deletion CYP2D6*5 was analyzed by a long PCR method. Detailed clinical information was obtained from 53 subjects. Patients genotyped homozygous or heterozygous for those CYP2D6 and CYP2C19 poor metabolizer alleles were treated for a longer time in hospital (median 57.5 vs. 40.0 days). Psychiatric patients might benefit from CYP genotyping, the duration of stay as inpatient might be reduced by a priori selection of the appropriate drug for the individual patient.
Authors:
Stefan Kropp; Ralf Lichtinghagen; Kathrin Winterstein; Jann Schlimme; Udo Schneider
Related Documents :
10647139 - Utilization and outcome in an overnight psychiatric observation program at a veterans a...
7948449 - Pentagastrin infusions in patients with panic disorder. i. symptoms and cardiovascular ...
9801629 - Staff's experiences with patients' assaults in a norwegian psychiatric university hospi...
18478169 - Mortality of finnish acute psychiatric hospital patients.
10606499 - Effectiveness of treatment for substance abuse and dependence for dual diagnosis patien...
9323339 - No differences in phospholipase-a2 activity between acute psychiatric patients and cont...
10584419 - Identification of familial hypercholesterolemia in taiwan: report of eleven cases.
21191609 - Benign paroxysmal positional vertigo nurse-led follow-up clinic.
18370499 - Influence of clinical diagnosis in the population pharmacokinetics of amikacin in inten...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical laboratory     Volume:  52     ISSN:  1433-6510     ISO Abbreviation:  Clin. Lab.     Publication Date:  2006  
Date Detail:
Created Date:  2006-07-03     Completed Date:  2006-07-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9705611     Medline TA:  Clin Lab     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  237-40     Citation Subset:  IM    
Affiliation:
Department of Clinical Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aryl Hydrocarbon Hydroxylases / genetics*
Cytochrome P-450 CYP2D6 / genetics*
Depression / drug therapy*,  metabolism
European Continental Ancestry Group
Genotype
Hospitals, Psychiatric
Humans
Length of Stay*
Middle Aged
Mixed Function Oxygenases / genetics*
Pilot Projects
Polymorphism, Genetic
Psychotropic Drugs / metabolism,  therapeutic use*
Schizophrenia / drug therapy*,  metabolism
Chemical
Reg. No./Substance:
0/Psychotropic Drugs; EC 1.-/Mixed Function Oxygenases; EC 1.14.14.1/Aryl Hydrocarbon Hydroxylases; EC 1.14.14.1/CYP2C19 protein, human; EC 1.14.14.1/Cytochrome P-450 CYP2D6

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hypochromic microcytic anemia as a clinical presentation of celiac disease.
Next Document:  Length of erythrocyte sedimentation rate (ESR) adjusted for the hematocrit: reference values for the...